Expert Voices from Boston Biotech Conferences

Expert Voices from Boston Biotech Conferences

Main menu

Skip to content
  • Home
  • Industry Musings
  • Featured Articles
  • Expert Q&A

Sub menu

Industry Musings

Boston’s prominence in medicine, music isn’t an accident

by Christoph Westphal • August 8, 2014

Read the full article on BostonGlobe.com ANDRIS NELSONS, the young new conductor of the Boston Symphony Orchestra, recently performed at the Tanglewood Gala Opening concerts. Listening to the exquisite performances, I was struck by the number of physicians and scientists…

Read more →

Industry Musings

Next GenDrugs

by Yvonne Greenstreet, SVP, Pfizer Specialty Care • August 4, 2014

Pfizer_Greenstreet-214x300

Looking at the long-term horizon, the innovative medicines and vaccines of tomorrow will likely come from a broad spectrum of sources and geographies, enabled by collaborations, alliances and partnerships. No one entity working in isolation will be sufficient to achieve…

Read more →

Industry Musings

On Financing Innovation

by William Heiden, CEO, AMAG Pharmaceuticals • August 4, 2014

AMAG. Bill Heiden

Financing innovation in our industry has historically been pursued through angel investors and venture capitalists. They provide the seed capital for a project or company so it can get to an early binary event, with additional infusions of capital needed…

Read more →

Industry Musings

Boston’s biotech, pharma success will breed more success

by Christoph Westphal • July 14, 2014

Read the full article published on bostonglobe.com BOSTON HAS benefited from an unexpected positive development in the last decade. Where we used to be simply the Hub of Biotech, we have suddenly turned into the Hub of the (Big) Pharma Universe.…

Read more →

Industry Musings

Protecting Boston’s biotech status

by Christoph Westphal • June 9, 2014

Read the full article on bostonglobe.com EAT LUNCH at Legal Seafood in Kendall Square any weekday, and you are likely to be surrounded by biomedical scientists from academia and biopharmaceutical companies. You might find the occasional information technology worker, but they…

Read more →

Industry Musings

Hepatitis C cure may be costly — but also cost effective

by Christoph Westphal • April 26, 2014

Read the full article on bostonglobe.com WHEN WAS the last time you heard of a genuine cure for a lethal disease? Hepatitis C has just been transformed from a chronic, and often fatal, condition to a disorder that can be…

Read more →

Industry Musings

Boston’s blooming biotech ecosystem

by Christoph Westphal • February 23, 2014

Read the full article on bostonglobe.com ONLY A few years ago, very few investors were interested in biotech. How quickly things change. Last year was the most active for biotechnology IPOs since 2000, with 38 biotech companies selling themselves on Wall…

Read more →

Industry Musings

Focusing On Fundamentals

by David Sable, MD, Special Situations Life Sciences Fund • February 6, 2014

The biotechnology and life sciences industries are built on a foundation of rapid and dramatic innovation in the basic sciences, an environment that can lead to well intentioned investing with poor outcomes. Part of the challenge is that companies in…

Read more →

Page 2 of 3
« 1 2 3 »

Recent Posts

  • Boston CEO Conference to Feature Prominent CEOs and Industry Leaders
  • BD Boston 2017 will gather top-tier leaders in life sciences to discuss industry-relevant topics on March 9 in Boston
  • An Open Letter to the BioPharma Community on Gender Diversity
  • The Paradox of Antibiotics Pricing
  • Diagnostics for Superbugs: A Lynchpin for Turning the Tables on this Global Scourge

Recent Comments

    Archives

    • May 2017
    • February 2017
    • January 2017
    • April 2016
    • July 2015
    • September 2014
    • August 2014
    • July 2014
    • June 2014
    • April 2014
    • February 2014
    • January 2014
    • August 2012

    Categories

    • Expert Q&A
    • Featured Articles
    • Industry Musings
    • Upcoming Conferences

    Meta

    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org

    Copyright © 2019 Expert Voices from Boston Biotech Conferences. All Rights Reserved. Magazine Basic created by c.bavota.